1. Home
  2. VTEX vs XNCR Comparison

VTEX vs XNCR Comparison

Compare VTEX & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VTEX

VTEX

VTEX

HOLD

Current Price

$3.92

Market Cap

752.7M

Sector

Technology

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$11.67

Market Cap

881.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTEX
XNCR
Founded
1999
1997
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
752.7M
881.9M
IPO Year
2019
2013

Fundamental Metrics

Financial Performance
Metric
VTEX
XNCR
Price
$3.92
$11.67
Analyst Decision
Buy
Buy
Analyst Count
6
9
Target Price
$5.97
$22.33
AVG Volume (30 Days)
1.0M
689.6K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
N/A
$125,576,000.00
Revenue This Year
$12.78
N/A
Revenue Next Year
$9.63
$4.80
P/E Ratio
$43.33
N/A
Revenue Growth
N/A
13.65
52 Week Low
$2.84
$6.92
52 Week High
$6.82
$18.69

Technical Indicators

Market Signals
Indicator
VTEX
XNCR
Relative Strength Index (RSI) 46.90 42.58
Support Level $3.92 $10.93
Resistance Level $4.21 $12.87
Average True Range (ATR) 0.18 0.69
MACD -0.04 -0.07
Stochastic Oscillator 16.15 6.12

Price Performance

Historical Comparison
VTEX
XNCR

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: